eli lilly's tirzepatide is the leader in weight loss sector loss, diabetes drug tops Keytruda as world's best-selling medicine Eli Lilly cracks down on
Description
A.TrujilloJ
95% CI: 0.190.94
Tirzepatide, being newer, has fewer reports and shorter follow-up periods, meaning the absence of evidence doesnt necessarily equate to safety
2021;9(3):e00750
Aroda VR, Ahmann A, Cariou B, Chow F, Davies MJ, Jdar E, Mehta R, Woo V, Lingvay I
We'll explore its specific uses and how it differs from dual-agonist therapies
